And I have noticed that a lot of key scientists around the world, some of the most cost-effective things we could do to improve lives of the most people is micronutrients.
I'm frustrated, because I've been working in this space for 5 or 6 years, and I'm kind of, 'All right. Where's the produ...
I think we should really look at a key issue, which is the economics of--you know, FDA and NIH can do all the work they ...
Less than 3 percent of the rare diseases have an FDA-approved treatment.
It doesn't seem like we're getting there yet with rare and neglected diseases.
The old model of a billion dollars to develop a drug doesn't work in this category.
I hope you can illuminate us on what's taking place, and what we can do to try to help out.
I wonder if you've surveyed some of the countries and places you're working, and ask them for the top 10 priorities that...
It's my hope that, in the future, when the good Samaritan story is told, it's the United States that's the one that stop...
Do you have any technical response or thoughts to it?
I hope you'll be willing to come to the Congress if there's statutory authority that's needed by you, NIH, AID, others, ...